|Bid||202.28 x 0|
|Ask||203.00 x 0|
|Day's range||201.80 - 204.00|
|52-week range||132.08 - 232.69|
|PE ratio (TTM)||53.29|
|Forward dividend & yield||2.28 (1.10%)|
|1y target est||N/A|
I would reinvest my BHP Billiton Limited (ASX:BHP) dividends in the shares of CSL Limited (ASX:CSL) and two others...
High net worth investors have lifted their bets on a rebound in the Australian dollar to the highest level since 2016 after the Aussie tumbled around 11% over the past year, according to Citigroup.
The dollar is sliding and companies like CSL Limited (ASX:CSL) and Orora Ltd (ASX:ORA) are benefiting due to their overseas operations.
The track record of these two LICs shows that in this space, often the oldest companies are the most reliable for income-focused investors.
CSL Limited (ASX:CSL) shares are one of three in the healthcare sector that I think could give portfolios a big lift...
Long-time underperformer Primary Health Care Limited (ASX:PRY) may finally have caught a lucky break, while outperforming CSL Limited (ASX:CSL) looks to be running out of puff.
The other week, in my article, “4 Common Mistakes Millennials make Stock Market Investing” I began to answer some of the questions I am frequently asked by my friends as a young investor. My aim is to one-by-one, discuss these questions, and de-bunk the misconceptions contained in them… The other week I answered the question, […]
The path of least resistance for the Australian dollar is down and that will create winners and losers on our share market. Here's what you need to know.
In June 2018, CSL Limited (ASX:CSL) announced its earnings update. Overall, the consensus outlook from analysts appear fairly confident, with earnings expected to grow by 13.5% in the upcoming yearRead More...
Over the last 5 years, CSL Limited (ASX:CSL) has delivered gains of well over 200% to its long term shareholders, demonstrating the explosive growth potential of companies in the biotech industry. Here are three under-the-radar medical companies that could be in the running to be the next CSL.
The most recent earnings announcement CSL Limited’s (ASX:CSL) released in June 2018 indicated that the company gained from a robust tailwind, eventuating to a double-digit earnings growth of 29.3%. Below,Read More...
It pains me to say this, but it may be time to take profit on one of my favourite stocks even as it flirts with a record high share price. Here's why...